Herve Besson

Adjusted comparison of daratumumab monotherapy versus real-world historical control data from the Czech Republic in heavily pretreated and highly refractory multiple myeloma patients

2018 | 1. lékařská fakulta, Lékařská fakulta v Hradci Králové

Publikace